{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-Follow-Up-and-Closure-of-Monitoring-Findings”
},
“headline”: “SOP for Follow-Up and Closure of Monitoring Findings”,
“description”: “This SOP defines procedures for the follow-up and closure of monitoring findings in clinical trials, ensuring timely CAPA implementation, documentation, and compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Follow-Up and Closure of Monitoring Findings

Purpose

The purpose of this SOP is to describe the standardized process for follow-up and closure of monitoring findings identified during clinical trial monitoring visits. This ensures that deviations, deficiencies, and non-compliance are corrected, preventive actions are taken, and all activities are fully documented for inspection readiness.

Scope

This SOP applies to CRAs, investigators, sponsors, CROs, study coordinators, and QA officers responsible for monitoring follow-up and CAPA management. It covers findings from onsite, remote, and central monitoring activities, including deviations, informed consent deficiencies, drug accountability issues, data entry delays, and protocol compliance concerns.

Responsibilities

• CRA/Monitor: Tracks findings, ensures CAPA is implemented, and documents closure.
• PI: Implements corrective actions at site level and provides CAPA responses.
• Study Coordinator: Assists PI in executing corrective measures and submitting evidence.
• Clinical Operations Manager: Oversees CAPA timelines and verifies resolution adequacy.
• Sponsor/CRO: Ensures follow-up findings are closed and reported per regulatory timelines.
• QA Officer: Reviews closed findings, verifies CAPA documentation, and audits process for compliance.

Accountability

The sponsor is accountable for ensuring all monitoring findings are addressed and closed. The CRA is accountable for documenting follow-up, while the PI is accountable for implementing corrective actions at site level.

Procedure

1. Identification of Findings
Document findings in Monitoring Visit Report (MVR).
Categorize findings as Critical, Major, or Minor.
Share findings with site PI within 10 working days.

2. CAPA Development
PI/site staff develop CAPA plan for each finding within 15 working days.
CAPA plan must address root cause, corrective action, and preventive action.
Submit CAPA plan to CRA and sponsor for review.

3. CAPA Implementation
Site executes corrective actions (e.g., retraining staff, updating records, revising procedures).
CRA verifies implementation during follow-up visit or remote review.
Record updates in CAPA Log (Annexure-1).

4. Documentation of Evidence
PI provides evidence of corrective actions (signed logs, updated consent forms, reconciliation reports).
CRA ensures all evidence is filed in TMF/ISF.

5. Closure Verification
CRA confirms CAPA effectiveness and documents closure in Finding Closure Log (Annexure-2).
Clinical Operations Manager approves closure.
QA performs independent review for selected findings.

6. Timelines
CAPA submission: within 15 working days of receiving MVR.
CRA follow-up verification: within 30 working days.
Closure approval: within 45 working days.

7. Escalation
If CAPA is not implemented or ineffective, escalate to sponsor immediately.
Document in Escalation Log (Annexure-3).

8. Archiving
Archive CAPA logs, closure documentation, and escalation records in TMF.
Retain for at least 15 years or per local regulations.

Abbreviations

• SOP: Standard Operating Procedure
• PI: Principal Investigator
• CRA: Clinical Research Associate
• CRO: Clinical Research Organization
• QA: Quality Assurance
• TMF: Trial Master File
• ISF: Investigator Site File
• CAPA: Corrective and Preventive Action
• MVR: Monitoring Visit Report

Documents

1. CAPA Log (Annexure-1)
2. Finding Closure Log (Annexure-2)
3. Escalation Log (Annexure-3)

References

• ICH E6(R2) – Good Clinical Practice
• FDA – Guidance on Risk-Based Monitoring
• EMA – Monitoring and CAPA Management
• CDSCO – Monitoring and CAPA Requirements
• WHO – Monitoring Follow-Up Guidance

Version: 1.0

Approval Section

Annexures

Annexure-1: CAPA Log

Annexure-2: Finding Closure Log

Annexure-3: Escalation Log

Revision History

For more SOPs visit: Pharma SOP